Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,304 | -58,194 | -34,338 | -136,125 | -109,054 |
| Depreciation Amortization | 1,726 | 1,087 | 880 | 4,452 | 3,939 |
| Accounts payable and accrued liabilities | -1,316 | -682 | -1,039 | -5,412 | -4,979 |
| Other Working Capital | 9,626 | 10,532 | 8,228 | -8,491 | -7,551 |
| Other Operating Activity | 16,520 | 7,672 | 3,823 | 27,366 | 23,456 |
| Operating Cash Flow | $-58,748 | $-39,585 | $-22,446 | $-118,210 | $-94,189 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57,770 | 35,315 | 21,243 | 30,473 | 33,357 |
| PPE Investments | -133 | -129 | -26 | -2,274 | -1,800 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -3,000 | -3,000 |
| Other Investing Activity | 0 | 0 | 0 | -3,000 | -3,000 |
| Investing Cash Flow | $57,637 | $35,186 | $21,217 | $25,199 | $28,557 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 89 | 89 | N/A | 433 | 371 |
| Other Financing Activity | 0 | 0 | 0 | -1,786 | -1,136 |
| Financing Cash Flow | $89 | $89 | $N/A | $-1,353 | $-765 |
| Beginning Cash Position | 34,601 | 34,601 | 34,601 | 128,965 | 128,965 |
| End Cash Position | 33,579 | 30,291 | 33,372 | 34,601 | 62,568 |
| Net Cash Flow | $-1,022 | $-4,310 | $-1,229 | $-94,364 | $-66,397 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,748 | -39,585 | -22,446 | -118,210 | -94,189 |
| Capital Expenditure | -133 | -129 | -26 | -2,274 | -1,800 |
| Free Cash Flow | -58,881 | -39,714 | -22,472 | -120,484 | -95,989 |